In a bid to tighten its regulatory control on the supply of infant formula in China, the Chinese Food & Drug Administration (CFDA) has set restrictions on the number of product lines baby powder manufacturers can sell in the country.Under the new rules, manufacturers will be restricted to offering just three infant formula product lines to Chinese consumers, with a maximum of three stages per product line.